TrialBritish journal of cancer2007

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma.

D M Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.